ArTS Archivio della ricerca di Trieste

CLAPS, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.986
AS - Asia 5.266
EU - Europa 3.551
SA - Sud America 813
Continente sconosciuto - Info sul continente non disponibili 446
AF - Africa 153
OC - Oceania 46
Totale 17.261
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.638
SG - Singapore 1.796
CN - Cina 1.186
IT - Italia 1.166
BR - Brasile 558
HK - Hong Kong 521
SE - Svezia 431
VN - Vietnam 406
KR - Corea 317
FR - Francia 277
BD - Bangladesh 264
DE - Germania 234
GB - Regno Unito 223
IN - India 198
RU - Federazione Russa 182
CA - Canada 180
NL - Olanda 171
PL - Polonia 154
FI - Finlandia 115
TR - Turchia 112
JP - Giappone 94
ES - Italia 88
IE - Irlanda 87
BG - Bulgaria 86
AR - Argentina 81
MX - Messico 71
ID - Indonesia 65
CO - Colombia 63
CH - Svizzera 62
AT - Austria 52
MA - Marocco 48
BE - Belgio 41
PK - Pakistan 41
AU - Australia 39
IR - Iran 39
UA - Ucraina 35
EC - Ecuador 32
IQ - Iraq 28
CL - Cile 27
PH - Filippine 27
RO - Romania 26
ZA - Sudafrica 26
TW - Taiwan 23
SA - Arabia Saudita 22
TN - Tunisia 19
EG - Egitto 18
MY - Malesia 18
CZ - Repubblica Ceca 17
JM - Giamaica 17
VE - Venezuela 17
CR - Costa Rica 14
GR - Grecia 14
PT - Portogallo 14
KE - Kenya 13
LT - Lituania 13
TH - Thailandia 13
JO - Giordania 12
IL - Israele 11
NP - Nepal 11
PY - Paraguay 11
UZ - Uzbekistan 11
AL - Albania 9
BO - Bolivia 8
HN - Honduras 8
HU - Ungheria 8
PE - Perù 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
KZ - Kazakistan 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
BB - Barbados 6
CU - Cuba 6
DK - Danimarca 6
HR - Croazia 6
NI - Nicaragua 6
NO - Norvegia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
ET - Etiopia 5
GE - Georgia 5
GH - Ghana 5
GT - Guatemala 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
BS - Bahamas 4
CI - Costa d'Avorio 4
KG - Kirghizistan 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
EU - Europa 3
GD - Grenada 3
LB - Libano 3
MM - Myanmar 3
PA - Panama 3
RS - Serbia 3
DZ - Algeria 2
EE - Estonia 2
Totale 16.784
Salva come PNG Salva come JPEG
Città #
Singapore 1.070
Ashburn 820
San Jose 580
Hong Kong 496
Chandler 332
Seoul 297
Hefei 282
Beijing 251
Chicago 246
Los Angeles 214
Trieste 212
Council Bluffs 204
Fairfield 186
Columbus 154
Boardman 144
Ho Chi Minh City 142
Santa Clara 128
Milan 126
Seattle 118
Ann Arbor 117
Wilmington 116
Princeton 115
New York 114
Lauterbourg 107
Zgierz 96
Dallas 94
Houston 92
Hanoi 86
Sofia 82
Woodbridge 82
Dublin 79
Buffalo 77
São Paulo 77
The Dalles 76
Moscow 75
Cambridge 68
Helsinki 66
Rome 66
Toronto 64
Frankfurt am Main 63
London 58
Phoenix 54
Bern 49
Jacksonville 49
Orem 48
Salt Lake City 44
Munich 43
Atlanta 42
Shanghai 41
Warsaw 41
Guangzhou 40
Elk Grove Village 37
Tokyo 37
Redwood City 35
Bogotá 33
Casablanca 33
Lappeenranta 32
Vienna 31
Montreal 30
Brooklyn 29
Boston 28
Brussels 28
Tampa 28
Washington 27
Chennai 26
Nuremberg 26
San Diego 26
Redmond 24
Denver 23
Istanbul 23
Manchester 22
Ankara 21
Palermo 21
Rio de Janeiro 21
Madrid 20
North Bergen 20
San Francisco 20
Mexico City 19
Paris 19
Düsseldorf 18
Haiphong 18
Tehran 18
Pune 17
Redondo Beach 17
Kingston 16
Memphis 16
Naples 16
Norwalk 16
Sterling 16
Turin 16
Amsterdam 15
Buenos Aires 15
Cleveland 15
Dhaka 15
Johannesburg 15
Poplar 15
Stockholm 15
Da Nang 14
Jakarta 14
Bengaluru 13
Totale 9.392
Salva come PNG Salva come JPEG
Nome #
Gender affirming surgery: Vaginoplasty and clitoroplasty with modified peno-scrotal flap technique 727
MtF sex reassignment surgery: Trombetta technique 565
Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer 534
Warm ischemia time length during on-clamp partial nephrectomy: dose it really matter? 299
Preoperative impact of albumin to fibrinogen ratio (AFR) on oncological outcomes in patients with muscle invasive bladder cancer treated with radical cystectomy 282
Focal testicular lesions. Multiparametric us features and association with histopathology 281
Utility of serum markers in the assessment of perioperative and postoperative morbidity and mortality after radical cystectomy 270
Testis Sparing Surgery of Small Testicular Masses: Retrospective Analysis of a Multicenter Cohort 264
Testis sparing surgery: Results of a large multicentric retrospective study 263
Analysis of clinical utility of abdominopelvic computer tomography in the follow up of Stage I Seminoma. A single center evaluation 246
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy 237
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients 237
Learning Curve for Endoscopic Combined Intra-Renal Surgery Using Vacuum-Assisted Device 235
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy 226
Analysis of clinical utility of abdominopelvic computer tomography in the surveillance of stage I seminoma. A single center evaluation 208
The role of preoperative controlling nutrtional status (CONUT) score in the assessment of pathological features and survival outcomes in clear-cell renal cell carcinoma (ccRCC): A population-based study 206
Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer 205
Impact of preoperative Controlling nutritional status (CONUT) score on perioperative morbidity and survival outcomes in patients with bladder cancer treated with radical cystectomy 194
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? 190
An Observational Cohort Study Investigating the Incidence Rate of Infectious Complications After Routine Office Nephrostomy Tube Replacement Without Using Antimicrobial Prophylaxis 188
Reliable Prediction of Post-Operative Complications’ Rate Using the G8 Screening Tool: A Prospective Study on Elderly Patients Undergoing Surgery for Kidney Cancer 186
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry 185
P-04-10 Italian Residents in Urology Sexual Health: A Multicentric Study 181
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets 179
Improving pre-operative planning of robot assisted nephron sparing surgery using three-dimensional anatomical model 178
A Review of Prostatitis 176
PD60-10 IMPACT OF PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE ON PERIOPERATIVE MORBIDITY AND SURVIVAL OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A MULTICENTER ANALYSIS 175
MP80-05 TREND, CHARACTERISTICS AND IMPACT ON CANCER-SPECIFIC MORTALITY OF INCIDENTAL RENAL MASSES: RESULTS FROM A LARGE SERIES OF AUTOPSIES 174
Impact of the COVID-19 pandemic on urology residency training in Italy 170
Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function? 167
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study 162
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study 162
Analysis of Bacterial Stent Colonization: The Role of Urine and Device Microbiological Cultures 161
Infective complications after nephrostomy tube replacement without use of antimicrobical prophylaxis: A prospective study 161
Procalcitonin as prognostic factor in patients with Fournier's gangrene 158
Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy 157
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer 157
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration 157
Time for a change in the management of small testicular masses: Results of a large multicentric retrospective study on testis sparing surgery 157
Validation of the Italian version of wisconsin stone quality of life (WISQOL): a prospective Italian multicenter study 156
Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study 156
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility 155
The role of preoperative cart score as predictor of renal functional decline after partial nephrectomy 155
Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives 154
Rebiopsy rate after transperineal or transrectal prostate biopsy 154
Optimization of the different therapeutic strategies in muscle invasive bladder cancer using biomarkers 154
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study 153
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 152
Risk factors of bladder cancer in patients undergoing transurethral cystoscopy: A multicentric italian experience from the IDENTIFY study cohort 152
The role of preoperative controlling nutritional status (CONUT) score in the assessment of survival outcomes in patients with muscle invasive bladder cancer (MIBC) treated with radical cystectomy: A pilot study 152
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis 150
Reliability of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: A precision study 149
Management of stuttering priapism 147
Preliminary results from an independent analysis of the italian cohort of the identify study: Baseline features of italian patients investigated for suspicious urinary tract malignancy at 5 italian tertiary referral centers 147
Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy 146
Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study 145
Impact of antiplatlet or anticoagulation therapy in patients newly diagnosed bladder cancer: Preliminary results of a independent analysis of the Identify Study Italian cohort 144
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 143
Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy 143
Plication surgery does not produce additional loss of length in Peyronie’s disease patients 140
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature 139
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 138
Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer 137
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE 137
Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores 136
Intraoperative laparoscopic ICG-guidance extended pelvic lymph node dissection in patients with intermediate and high-risk prostate cancer who underwent radical prostatectomy: A matched case-control study 133
Frequency of testicular torsion presenting with abdominal pain in adults: a retrospective analysis of diagnostic and management implications 132
COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers 132
Fluorescence Confocal Microscopy in Urological Malignancies: Current Applications and Future Perspectives 129
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum 125
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 124
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival 124
Targeted Prostate Biopsy: How, When, and Why? A Systematic Review 117
Novel Expanding Renal Cell Carcinoma Biomarkers 116
MP46-17 INFECTIVE COMPLICATIONS AFTER NEPHROSTOMY TUBE REPLACEMENT WITHOUT USE OF ANTIMICROBICAL PROPHYLAXIS: A PROSPECTIVE STUDY 115
Focus on the Use of Resveratrol in Bladder Cancer 114
The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma 114
External validation of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: a multicentric prospective study 114
Arterioureteral fistula: An unusual cause of haematuria 10 years after the implantation of a synthetic iliac-femoral stent 112
Prostate cancer patients with lymphatic node involvement detected by immunohistochemistry. Is the effort worthwhile? 111
Exploring the Residents’ Perspective on Smart learning Modalities and Contents for Virtual Urology Education: Lesson Learned During the COVID-19 Pandemic 109
Smart learning for urology residents during the COVID-19 pandemic and beyond: insights from a nationwide survey in Italy 107
The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study 107
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY study 106
Editorial Comment [to "Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes"] 105
The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series 102
Reply by Authors 99
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 97
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study 96
Promising Biomarkers in Renal Cell Carcinoma 95
MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY 94
Enhanced prognostic value of four‐tier hybrid grading system in Ta non‐muscle‐invasive bladder cancer 93
Laroscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of Indocyanine Green: Results from a prospective study 92
Slowdown of urology residents’ learning curve during the COVID-19 emergency 92
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 89
Laparoscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of indocyanine green: Results from a prospective study 89
Molecular markers of systemic therapy response in urothelial carcinoma 86
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy 85
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy 84
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding 81
Totale 16.614
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022744 0 0 75 110 25 26 37 55 121 99 31 165
2022/20231.393 127 205 76 180 62 204 51 127 178 55 77 51
2023/20241.483 103 75 79 81 121 138 289 224 42 56 151 124
2024/20253.356 102 257 364 317 270 269 212 158 447 370 264 326
2025/20267.717 966 412 600 685 525 607 877 289 654 913 514 675
2026/20271.205 513 434 258 0 0 0 0 0 0 0 0 0
Totale 17.261